Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies.

Front Immunol · 2022 · PMC9376239 · PMID 35979372

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although acalabrutinib-treated patients also showed a trend in reduced Treg to CD4+ ratio compared to baseline, these differences were not significant ( 108 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.